Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4; this appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows Revision: v3.5.4 as the current version, replacing the previous v3.5.3.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision label changed from v3.5.2 to v3.5.3, indicating a newer version of the page. This change is a metadata update rather than a modification to study data or content.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter revision label updated from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded 'Carcinoma of esophagus' to the conditions listed for the study.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.